Recombinant multi-species CACNA1I protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CACNA1I protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the pore-forming alpha subunit of a voltage gated calcium channel. The encoded protein is a member of a subfamily of calcium channels referred to as is a low voltage-activated, T-type, calcium channel. The channel encoded by this protein is characterized by a slower activation and inactivation compared to other T-type calcium channels. This protein may be involved in calcium signaling in neurons. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
The Alternative Names of target: CACNA1I,CACNA1L,Ca(V)3.3,Ca(v)3.3,Cacna1i,Cav3.3,NEDSIS,Voltage-dependent T-type calcium channel subunit alpha-1I,Voltage-gated calcium channel subunit alpha Cav3.3 (Ca(v)3.3),ca(v)3.3

Target products collectionGo to CACNA1I products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0136-Ag-1/ GM-Tg-hg-IP0136-Ag-2 Human CACNA1I protein Human
GM-Tg-rg-IP0136-Ag-1/ GM-Tg-rg-IP0136-Ag-2 Rat CACNA1I protein Rat
GM-Tg-mg-IP0136-Ag-1/ GM-Tg-mg-IP0136-Ag-2 Mouse CACNA1I protein Mouse
GM-Tg-cynog-IP0136-Ag-1/ GM-Tg-cynog-IP0136-Ag-2 Cynomolgus/Rhesus macaque CACNA1I protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0136-Ag-1/ GM-Tg-felg-IP0136-Ag-2 Feline CACNA1I protein Feline
GM-Tg-cang-IP0136-Ag-1/ GM-Tg-cang-IP0136-Ag-2 Canine CACNA1I protein Canine
GM-Tg-bovg-IP0136-Ag-1/ GM-Tg-bovg-IP0136-Ag-2 Bovine CACNA1I protein Bovine
GM-Tg-equg-IP0136-Ag-1/ GM-Tg-equg-IP0136-Ag-2 Equine CACNA1I protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0136-Ag-1/ GM-Tg-hg-IP0136-Ag-2; GM-Tg-rg-IP0136-Ag-1/ GM-Tg-rg-IP0136-Ag-2;
GM-Tg-mg-IP0136-Ag-1/ GM-Tg-mg-IP0136-Ag-2; GM-Tg-cynog-IP0136-Ag-1/ GM-Tg-cynog-IP0136-Ag-2;
GM-Tg-felg-IP0136-Ag-1/ GM-Tg-felg-IP0136-Ag-2; GM-Tg-cang-IP0136-Ag-1/ GM-Tg-cang-IP0136-Ag-2;
GM-Tg-bovg-IP0136-Ag-1/ GM-Tg-bovg-IP0136-Ag-2; GM-Tg-equg-IP0136-Ag-1/ GM-Tg-equg-IP0136-Ag-2
Products Name CACNA1I protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CACNA1I
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CACNA1I protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.